Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease

Biomarkers of brain Aβ amyloid deposition can be measured either by cerebrospinal fluid Aβ42 or Pittsburgh compound B positron emission tomography imaging. Our objective was to evaluate the ability of Aβ load and neurodegenerative atrophy on magnetic resonance imaging to predict shorter time-to-prog...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jack, Clifford R., Wiste, Heather J., Vemuri, Prashanthi, Weigand, Stephen D., Senjem, Matthew L., Zeng, Guang, Bernstein, Matt A., Gunter, Jeffrey L., Pankratz, Vernon S., Aisen, Paul S., Weiner, Michael W., Petersen, Ronald C., Shaw, Leslie M., Trojanowski, John Q., Knopman, David S.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2010
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2965425/
https://ncbi.nlm.nih.gov/pubmed/20935035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/brain/awq277
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados